4.8 Letter

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 16, Pages -

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2201849

Keywords

-

Funding

  1. National Institutes of Health [CA260476]
  2. Reproductive Scientist Development Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD000849]
  3. Bur-roughs Wellcome Fund

Ask authors/readers for more resources

Although immunity from two doses of BNT162b2 vaccine diminishes over time, a booster dose significantly enhances the neutralizing antibodies against both the BA.1 and BA.2 variants.
Neutralization of Omicron BA.1 and BA.2 VariantsAlthough two doses of BNT162b2 vaccine produce immunity that wanes over time, the administration of a booster dose substantially increases the level of neutralizing antibodies against both the BA.1 and BA.2 variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available